For most enterprises, Devstral Small 2 will serve either as a low-friction way to prototype—or as a pragmatic bridge until ...
Investors sent Structure Therapeutics' stock flying high after the company disclosed results from two studies testing ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a foc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback